NEW YORK (GenomeWeb) – Alere confirmed today that it is in full compliance with its merger agreement with Abbott Laboratories following a report Wednesday that Abbott was exercising its contractual right to audit the books and records of Alere, and that Abbott had received a partial response from Alere.

"We are confident that the transaction will be completed in accordance with its terms," said Jackie Lustig, senior director of corporate communications at Alere. "That's all we can say at this time."

Abbott officials did not return calls to GenomeWeb seeking comment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.